RNA News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-13 | Current report | SEC filing | Atrium Therapeutics, Inc. filed Form 8-K | Atrium Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-07-14 | Current report | SEC filing | Atrium Therapeutics, Inc. filed Form 8-K | Atrium Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-05-14 | Current report | SEC filing | Atrium Therapeutics, Inc. filed Form 8-K | Atrium Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-02-27 | Current report | SEC filing | Atrium Therapeutics, Inc. filed Form 8-K | Atrium Therapeutics, Inc. filed Form 8-K covering items 1.01,5.01,5.02,9.01. |
| 2026-02-26 | Current report | SEC filing | Atrium Therapeutics, Inc. filed Form 8-K | Atrium Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |